Celldex Therapeutics reported $-17324000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US $ 2378M 45M
Applied Genetic Technologies AGTC:US $ -16003000 2.62M
Aptinyx Inc APTX:US $ -21206000 1.34M
Arena Pharmaceuticals ARNA:US $ -124485000 19.91M
Biocept BIOC:US $ 501.54K 2.25M
Bristol Myers Squibb BMY:US $ 2985M 18M
Celldex Therapeutics CLDX:US $ -17324000 3.88M
Glaxosmithkline GSK:US 2.67B 712M
Immunogen IMGN:US $ -34234000 6.86M
Merrimack Pharmaceuticals MACK:US $ -886000 21K
Nektar Therapeutics NKTR:US $ -113596000 3.39M
Newlink Genetics NLNK:US -7497000 1.17M
Northwest Biotherapeutics NWBO:US -10049000 2.36M
Pfizer PFE:US $ 9254M 2592M
Rigel Pharmaceuticals RIGL:US $ -19785000 6.74M
Seattle Genetics SGEN:US $ -297963000 208.36M